F. Hoffmann-La Roche Co

F. Hoffmann-La Roche Co., Ltd. (F. Hoffmann-La Roche Ltd, commonly known as Roche) is a Swiss pharmaceutical company, one of the world's leading pharmaceutical companies and ranked first in the world in the field of diagnostics. Is one of the manufacturers of biotechnological drugs in the field of oncology, virology, rheumatology and transplantation. Founded in 1896 in Basel. It has offices in 150 countries and a staff of 80,000 employees. For more than 100 years, Roche has made significant contributions to global health. Twenty-four Roche drugs, including vital antibiotics, antimalarials, and chemotherapeutic drugs, are included in the WHO List of Essential Medicines. In 2014, the Roche Group had more than 88,500 employees, R&D investment of 8.9 billion Swiss francs and sales of 47.5 billion Swiss francs. Roche is wholly owned by Genentech, USA (as of March 26, 2009) and a controlling stake in Chugai Pharmaceutical, Japan (中外 製 薬 Tu: Guy Seiyaku). Roche's divisions are Pharma (Medicines) and Diagnostics (Diagnostic Equipment). The Chairman of the Board of Directors is Franz B. Humer, and the Chief Executive Officer of the Roche Group of Companies is Severin Schwan. The first Roche office in Ukraine was registered on January 8, 1998.